| Patents for C07D 271 - Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms (7,144) |
|---|
| 11/06/2007 | USRE39916 Compounds that modulate PPAR activity and methods for their preparation |
| 11/01/2007 | WO2007124024A2 SYNTHESIS OF 5-ß-KETO-1,2,4-OXADIAZOLES AND CONVERSION OF 5-ß-KETO-1,2,4-OXADIAZOLES TO N-PYRAZOLYL AMIDOXIMES |
| 11/01/2007 | WO2007123225A1 Oxadiazolidinedione compound |
| 11/01/2007 | WO2007075598A3 N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase |
| 11/01/2007 | CA2650124A1 Oxadiazolidinedione compound |
| 10/31/2007 | EP1848707A1 Awthranilic acid derivatives and their use in treatment of diseases of lipid metabolism, in particular dyslipidaemia |
| 10/31/2007 | EP1848699A1 Anthranilic acid derivatives as hm74a receptor agonists |
| 10/31/2007 | EP0910564B1 D-amino acid derived inhibitors of cysteine and serine proteases |
| 10/31/2007 | CN101062023A Selective androgen receptor modulators and methods of use thereof |
| 10/25/2007 | US20070249691 Mercaptoimidazoles as Ccr2 Receptor Antagonists |
| 10/24/2007 | EP1846380A1 Cardiovascular compounds comprising heterocyclic nitric oxide donor group compositions and methods of use |
| 10/24/2007 | EP1846372A2 Compounds for inflammation and immune-related uses |
| 10/24/2007 | EP1534671A4 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 10/23/2007 | US7285568 Substituted p-(2-alkoxy-2-acylethyl)biphenyl compounds, e.g., 1-[4'-(2-ethoxy-3-morpholin-4-yl-3-oxopropyl)biphenyl-3-yl]-3-heptyl-1-methylurea; useful in human or veterinary medicine: dermatology, cardiovascular diseases, immune diseases, and diseases associated with lipid metabolism |
| 10/23/2007 | US7285558 Helicobacter infections; bactericides |
| 10/18/2007 | US20070244138 antiinflammatory agents |
| 10/18/2007 | US20070244119 enzyme ihibitors such as 3-{5-[(1R)-1-amino-1-methyl-2-phenylethyl]-1,3,4-oxadiazol-2-yl}-N-[(1R)-1-(4-fluorophenyl)ethyl]-5-[methyl(methylsulfonyl)amino]benzamide, used for treating neurodegenerative diseases |
| 10/18/2007 | US20070243416 Amine Compound and Organic Electroluminescent Element Employing the Same |
| 10/11/2007 | WO2007113634A1 Novel dipeptidyl peptidase iv inhibitors and processes for their preparation and pharmaceutical compositions containing them |
| 10/11/2007 | CA2682846A1 Novel dipeptidyl peptidase iv inhibitors and processes for their preparation and pharmaceutical compositions containing them |
| 10/10/2007 | EP1841428A1 Novel quinolinium salts and derivatives |
| 10/10/2007 | EP1841426A1 Tertiary carbinamines having substituted heterocycles, which are active as inhibitors of beta-secretase, for the treatment of alzheimer's disease |
| 10/10/2007 | CN100341496C Preventive or therapeutic agent for kidney disease |
| 10/09/2007 | US7279490 Ophthalmic compositions for treating ocular hypertension |
| 10/09/2007 | US7279444 for controlling undesirable plants |
| 10/03/2007 | EP1838304A2 Heterocyclic aspartyl protease inhibitors |
| 10/03/2007 | CN101045714A Amino-acid biphenyl compound and medicine usage thereof |
| 09/27/2007 | US20070225365 Cetp Inhibitors |
| 09/26/2007 | EP1836158A1 Fused bicyclic carboxamide derivatives for use as cxcr2 inhibitors in the treatment of inflammation |
| 09/26/2007 | EP1836149A1 Phenylbenzoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic uses thereof |
| 09/26/2007 | CN101043887A 2-(aryl)azacyclylmethyl carboxylates, sulfonates, phosphonates, phosphinates and heterocycles as s1p receptor agonists |
| 09/20/2007 | WO2007104719A1 Diphenylurea derivatives and their use as chloride channel blockers or bkca channel modulators |
| 09/20/2007 | WO2005019190A3 (4 -amino -1,2, 5-oxadiazol-4-yl) -hetξroaromatic compounds useful as protein kinase inhibitors |
| 09/20/2007 | CA2646336A1 Diphenylurea derivatives and their use as chloride channel blockers or bkca channel modulators |
| 09/19/2007 | EP1833806A1 Oxadiazole derivatives as dgat inhibitors |
| 09/19/2007 | EP1833804A1 Aryl sulphonamide modulators |
| 09/19/2007 | CN100338073C Substituted phenylacetic acids |
| 09/18/2007 | US7271406 Electron transport agents for organic electronic devices |
| 09/18/2007 | US7271267 Nitrobenzodifuroxan compounds, including their salts, and methods thereof |
| 09/18/2007 | US7271168 Piperazine derivatives having SST1 antagonistic activity |
| 09/13/2007 | US20070213329 Sulphones which modulate the action of gammasecretase |
| 09/13/2007 | US20070213316 N,N'-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 09/12/2007 | EP1831145A1 Substituted oxyarenes |
| 09/12/2007 | EP1830837A2 Heterocyclic derivatives for the treatment of diseases mediated by stearoyl-coa desaturase enzymes |
| 09/06/2007 | DE102006009928A1 Substituierte Arylsulfonamide Substituted aryl sulfonamides |
| 09/05/2007 | EP1829858A2 Dibenzylamine compounds and pharmaceutical use thereof |
| 09/05/2007 | EP1373233B1 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same |
| 09/04/2007 | US7265246 7-Aminoakyl-2-arylcarbonylaminoindanes, e.g., 3-Fluorobiphenyl-4-carboxylic acid (R)-(6-((3-ethoxypropylamino)methyl)-2R-hydroxyindan-1-yl)amide; treatment of cognitive impairment associated with schizophrenia, Alzheimer's disease, and psychoses |
| 09/04/2007 | US7265139 RXR activating molecules |
| 08/30/2007 | WO2007098474A1 Phenyl-cycloalkyl and phenyl-heterocyclic derivatives as s1p receptor agonists |
| 08/30/2007 | US20070203205 treatment and/or prevention of adverse conditions of the central nervous system, including sleep disorders such as insomnia, psychotic disorders such as schizophrenia and psychiatric disorders such as anxiety; example (1S)-1-[2-({4-[(E)-2-(4-fluorophenyl)vinyl]phenyl}sulfonyl)phenyl]ethanol |
| 08/30/2007 | US20070203138 Novel Compounds and Compositions as Cathepsin S Inhibitors |
| 08/30/2007 | CA2641661A1 Phenyl-cycloalkyl and phenyl-heterocyclic derivatives as s1p receptor agonists |
| 08/29/2007 | EP1824821A2 Carbazole, carboline and indole derivatives useful in the inhibition of vegf production |
| 08/29/2007 | EP1824817A1 Arylsulfonylnaphthalene derivatives as 5ht2a antagonists |
| 08/28/2007 | US7262318 Substituted heteroaryl- and phenylsulfamoyl compounds |
| 08/23/2007 | US20070197522 Dpp-iv inhibitors |
| 08/22/2007 | CN101020687A New thiobizole formanide derivative and its synthesis process and bioactivity |
| 08/22/2007 | CN101020667A New compound with activity of inducing secondary metabolism of Hypericum plant |
| 08/21/2007 | CA2304965C ((cyclo)alkyl substituted)-gamma-aminobutyric acid derivatives (=gaba analogues), their preparation and their use in the treatment of neurological disorders |
| 08/16/2007 | WO2007092638A1 Bicyclic sphingosine 1-phosphate analogs |
| 08/16/2007 | WO2007092190A2 Methods and compositions for modulating sphingosine-1-phosphate (s1p) receptor activity |
| 08/16/2007 | WO2007091701A1 Discotic nematic material, composition, retardation plate, elliptically-polarizing plate and compound |
| 08/16/2007 | WO2007019397A3 6-membered aryl and heteroaryl derivatives for the treatment of hepatitis c virus |
| 08/16/2007 | CA2641718A1 Bicyclic sphingosine 1-phosphate analogs |
| 08/15/2007 | EP1818326A1 Nitrogen-containing heterocyclic compounds and pharmaceutical composition containing the compounds |
| 08/15/2007 | EP1818325A2 3,4-DI-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
| 08/15/2007 | EP1817305A2 Compounds for the treatment of cns and amyloid associated diseases |
| 08/14/2007 | US7256204 6-(4-biphenylyl)methoxy-2-(2-(N,N-dimethylamino)ethyl)tetralin for example; inhibiting amyloid-beta protein production; for neurodegenerative diseases such as Alzheimer's disease |
| 08/08/2007 | CN101014565A Diarylsulfones as 5-HT2a antagonists |
| 08/08/2007 | CN101014564A Substituted acids for the treatment of respiratory diseases |
| 08/08/2007 | CN101012206A 5-Methyl-1,3,4-oxadiazole-2(3H)-ones and preparing method thereof |
| 08/02/2007 | WO2007085451A2 3,5-di (aryl or heteroaryl) isoxazoles and 1, 2, 4-oxadiazoles as s1p1 receptor agonists, immunosuppresssive and anti -inflammatory agents |
| 08/02/2007 | US20070179157 Nonnucleoside reverse transcriptase inhibitors |
| 08/02/2007 | US20070179154 Coumarin derivatives, process for their production and use thereof |
| 08/02/2007 | CA2637081A1 3,5-di (aryl or heteroaryl) isoxazoles and 1, 2, 4-oxadiazoles as s1p1 receptor agonists, immunosuppressive and anti -inflammatory agents |
| 08/01/2007 | CN101007791A Amino acid diphenyl compound |
| 07/31/2007 | US7250433 Calcium channel blockers; central nervous system disorders; antiarthritic agents |
| 07/26/2007 | US20070173498 Melanin concentrating hormone antagonist |
| 07/25/2007 | EP1499600B1 Heteroaryl substituted biphenyl derivatives as p38 kinase inhibitors |
| 07/25/2007 | CN1328247C N-biphenylmethyl aminocycloalkanecarboxamide derivatives with a substiituent on the methyl useful as bradykinin antagonists |
| 07/25/2007 | CN101005837A 有丝分裂驱动蛋白抑制剂 Mitotic kinesin inhibitors |
| 07/25/2007 | CN101003521A A compound valeryl biphenyl of valine |
| 07/25/2007 | CN101003520A A compound butyryl biphenyl of valine |
| 07/24/2007 | US7247748 E.g., 2-(3-{3-[(2-chloro-3-(trifluoromethyl)-benzyl)-(2,2-diphenylethyl)-amino]-propoxy}phenyl)-1-morpholin-4-yl-ethanone; agonists of the nuclear receptors, LXR alpha and LXR beta used to increase ABCA1, ABCG1, and apolipoprotein E expression and reverse cholesterol transport |
| 07/24/2007 | US7247744 Reacting a probucol derivatives with succinic, glutaric, adipic, suberic, sebacic, azelaic, phthalic or maleic anhydride in the presence of a prophosphatrane to form a water soluble mono- or bis(carboxyalkanoyl ester) |
| 07/19/2007 | WO2007079931A1 Substituted oxadiazole derivatives and their use as opioid receptor ligands |
| 07/19/2007 | CA2634562A1 Substituted oxadiazole derivatives and their use as opioid receptor ligands |
| 07/18/2007 | EP1807393A1 Diarylsulfones as 5-ht2a antagonists |
| 07/18/2007 | CN100999481A Selective androgen receptor modulators and methods of use thereof |
| 07/17/2007 | CA2432643C 3-ox(adi)azolylpropanohydroxamic acids useful as procollagen c-proteinase inhibitors |
| 07/12/2007 | US20070161687 1,2,4-Oxadiazole benzoic acid compositions and their use for nonsense suppression and the treatment of disease |
| 07/11/2007 | EP1805144A1 Heterocyclical chromophore architectures |
| 07/11/2007 | EP1804793A2 2-(aryl)azacyclylmethyl carboxylates, sulfonates, phosphonates, phosphinates and heterocycles as s1p receptor agonists |
| 07/11/2007 | EP1804785A2 Diaryl ureas as cb1 antagonists |
| 07/11/2007 | CN1997626A Inhibitors of histone deacetylase |
| 07/10/2007 | US7241793 For therapy of cardiovascular diseases |
| 07/05/2007 | WO2007074893A1 Oxadiazole derivative, and light emitting element, light emitting device, and electronic device using the oxadiazole derivative |
| 07/05/2007 | US20070155748 N-sulfonyl-alpha-amino-acid derivatives |
| 07/05/2007 | CA2634198A1 N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase |